TY  - JOUR
TI  - Polypharmacy Frequency: The Relationship Between
Polypharmacy and Mortality in COVID-19 (+) Older Adults
AB  - Objective: This study aims to determine the relationship between polypharmacy and Coronavirus disease-2019 (COVID-19) (+) related mortality.
Materials and Methods: All older adults >60 years old who had positive COVID-19 polymerase chain reaction tests were included in the study,
designed retrospectively. Polypharmacy was defined as drug use of five or more.
Results: One hundred and ten people of >60 years old were included in the study. Fifty-nine (53.6%) of the participants were male and the mean
age was 70.5+8.81. The prevalence of polypharmacy in patients diagnosed with COVID-19 infection was 31.8% (n=35). Eighty-two (78.8%) of
participants had pneumonia. Mortality occurred in 24 (21.8%) of the participants. There was no relationship between polypharmacy and mortality
(p=0.241). In multivariate analysis, older age was associated with mortality (odds ratio: 6.82 95% confidence interval: 2.46-18.91, p<0.001).
Conclusion: The prevalence of polypharmacy in individuals diagnosed with COVID-19 infection was like the literature. The most significant factors
in death in people with COVID-19 infection were older age. There was no relationship between polypharmacy and mortality.
AU  - Ertürk Zararsız, Gözde
AU  - Akın, Sibel
AU  - TÜRE, Zeynep Ture
AU  - DURMUS, Nurdan SENTURK
AU  - Soysal, Tuba
DO  - 10.4274/ejgg.galenos.2021.478
PY  - 2022
JO  - European journal of geriatrics and gerontology (Online)
VL  - 4
IS  - 1
SN  - 2687-2625
SP  - 5
EP  - 10
DB  - TRDizin
UR  - http://search/yayin/detay/527186
ER  -